Economic evaluation of cancer treatments: methodological and practical issues

Citation
Ca. Uyl-de Groot et Ckr. Touw, Economic evaluation of cancer treatments: methodological and practical issues, ANTI-CANC D, 9(10), 1998, pp. 835-841
Citations number
18
Categorie Soggetti
Pharmacology,"Onconogenesis & Cancer Research
Journal title
ANTI-CANCER DRUGS
ISSN journal
09594973 → ACNP
Volume
9
Issue
10
Year of publication
1998
Pages
835 - 841
Database
ISI
SICI code
0959-4973(199811)9:10<835:EEOCTM>2.0.ZU;2-1
Abstract
Economic evaluation is a comparative analysis of alternatives in terms of b oth their costs and consequences. Therefore, the basic task of economic eva luation is to identify, measure, value and compare the costs and effects of the alternatives being considered. In this paper, the methodology of econo mic evaluation in general and in cancer in particular is reviewed and pract ical issues are illuminated. In the treatment of cancer patients not only s urvival and disease-free survival are important outcome parameters, but als o quality of years alive. Hence, specific attention is given to the measure ment and valuation of quality of life. Economic evaluation is intended to s upport health policy at different levels of decision making. In cancer trea tment, health policy concerns both preventive, curative and palliative stra tegies, and decisions are often made at the micro and macro level. Economic evaluation can provide essential information on the costs and benefits of each option, and consequently on the optimal policy mix, and thus support d ecisions on the adoption and utilization of new treatments. Such informatio n may assist policy makers in formulating regulatory policies and legislati on, industry in developing products, health professionals in treating and s erving patients, and consumers in making personal health decisions. [(C) 19 98 Lippincott Williams & Wilkins.].